FTSE rises to record close, blue-chips shrug off Reckitt blip
Reuters
Published Oct 18, 2017 17:43
FTSE rises to record close, blue-chips shrug off Reckitt blip
By Kit Rees and Helen Reid
LONDON (Reuters) - British mid-caps jumped to a record closing level on Wednesday as investors grew more comfortable with the smaller, more domestically-focused stocks, while the FTSE 100 held its ground as third quarter earnings trickled in.
The FTSE 250 (FTMC) was up 0.6 percent on the day, closing at a record 20,263.1 points. Mid-caps have strongly outperformed the bigger index this year, up around 12 percent against the FTSE 100's 6 percent rise.
"Investors are starting to feel safer with mid-caps, and more worried about a series of warnings on big FTSE companies," said Colin McLean, managing director at SVM Asset Management.
Smaller companies which occupy niches in sectors like tech and retail, with disruptive potential, are drawing in investors keen for growth, he added.
"If a mid-cap business does one thing and does it well, people feel more comfortable about its capacity to take business away from other global businesses," said McLean.
The blue chip FTSE 100 (FTSE) index was up 0.4 percent, helped by a weaker pound following data showing UK wage growth edged above forecasts, bolstering expectations for a Bank of England rate hike.
Shares in Reckitt Benckiser fell 2.5 percent after the consumer goods firm cut its full-year sales forecast, struggling with fallout from a cyber attack, a failed product launch and a safety scandal in South Korea.
Reckitt also said it will split into two business units.
"Of all the profits warnings we've seen of late, this is by far the best received perhaps because the Q3 performance is still actually fairly good and we don't see things getting markedly worse in Q4 for the full year," Mike van Dulken, head of research at Accendo Markets, said.
Healthcare firm Shire (L:SHP) was the worst faller, down 3.1 percent after Citigroup (NYSE:C) removed it and Swiss pharma firm Roche (S:ROG) from its "focus list" of stocks, instead naming AstraZeneca its top pick.
Miner Rio Tinto (L:RIO) declined 3 percent after the U.S. Securities and Exchange Commission charged it and two of its former top executives with fraud.
Financials added the most points to the index, with HSBC (L:HSBA), Prudential (L:PRU) and Legal & General (L:LGEN) all rising 0.6 to 1.1 percent as analysts said the likelihood of a November rate hike from the Bank of England rose.
Get The App
Mid- and small-cap companies saw the most dramatic share price moves on the day.
Shares in tech firm Softcat (L:SCTS) rose 6 percent after it reported an increase in full-year revenue, though Nostrum Oil & Gas (L:NOGN) dropped 3 percent after saying it expected to see a hit to production in the first half of 2018.
Spire Healthcare (L:SPI) jumped 8.6 percent after broker Panmure Gordon upgraded its view on healthcare stocks, saying Spire's 19 percent drop in mid-September was the main reason for recent underperformance in a UK life sciences sector it saw entering a strong period.
Airline Flybe (L:FLYB) plummeted 20.5 percent after issuing a profit warning, with higher maintenance costs weighing on performance.
"The worry is that (Flybe's) cost base isn’t strong enough to weather the headwinds facing the sector," Neil Wilson, senior market analyst at ETX Capital, said.
"Many small and mid-sized carriers are limping on thanks to cheap oil but further consolidation looks inevitable as capacity growth shrinks margins at the less competitive carriers," Wilson added.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.